Solidra Plus Ophthalmic Solution - Vietnam Registration 240000766/PCBB-HN
Access comprehensive regulatory information for Solidra Plus Ophthalmic Solution in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240000766/PCBB-HN and manufactured by OFTALPHARMA SRL. The authorized representative in Vietnam is CÔNG TY TNHH VẬT TƯ Y TẾ ĐỖ TRẦN.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
240000766/PCBB-HN
000.00.19.H26-240408-0014
Ophthalmic Solution
Technical Details
Solidra Plus is a medical device used in ophthalmology, containing a solution of hypotonic saline, sterile with high biocompatibility, low viscosity, physiological pH, and without preservatives, with the combination of Cross-linked Sodium Hyaluronate and Sodium Hyaluronate of medium molecular weight, packed in a 10ml vial. Cross-linked Sodium Hyaluronate has a network-like molecular structure combined with Linear Sodium Hyaluronate of medium molecular weight, which enhances the lubricating, hydrating, and long-lasting effects on the eye surface, thereby alleviating symptoms associated with dry eye syndrome. Solidra Plus is recommended for reducing redness, dryness, and fatigue caused by dry eye syndrome, due to environmental stress (smoke, allergens, fog, air conditioning, etc.) and eye strain from prolonged use of computers, televisions, and video screens. The product can be used by contact lens wearers without removing their lenses, to improve the lubrication and comfort of the eyes.
Dates and Status
Apr 12, 2024

